Table 3.
ROI FA | Beta | 95% CI lower–upper | T | FDRp | r2 |
---|---|---|---|---|---|
PTR R | 66.70 | −28.60, 162.01 | 1.45 | 0.64 | 0.07 |
PTR L | −20.75 | −166.765, 125.26 | −2.45 | 0.99 | < 0.01 |
SS R | 27.84 | −158.94, 214.61 | 0.31 | 0.99 | < 0.01 |
SS L | 30.75 | −126.08, 187.58 | 0.41 | 0.99 | 0.01 |
DC R | 82.49 | 0.59, 164.49 | 2.08 | 0.38 | 0.13 |
DC L | −3.42 | −92.47, 85.63 | −0.080 | 0.94 | < 0.01 |
VC R | −41.68 | −122.04, 38.68 | −1.07 | 0.78 | 0.04 |
VC L | 7.94 | −74.78, 90.67 | 0.20 | 0.94 | < 0.01 |
DC R, dorsal cingulum right hemisphere; DC L, dorsal cingulum right hemisphere; FDR, false discovery rate corrected p-value; PTR R, posterior thalamic radiation right hemisphere; PTR L, posterior thalamic radiation left hemisphere; R2, r squared; SS R, sagittal stratum; ROI, region of interest; SS R, sagittal stratum right hemisphere; SS L, sagittal stratum left hemisphere; T, variance; VC R, ventral cingulum right hemisphere; VC L, ventral cingulum left hemisphere; 95% CI lower–upper, 95% confidence interval.